123- Signaling Specific Inhibitors of the CB1 Receptor (CB1-SSi) for Cannabis Use Disorder: From Chemical Development to a Randomized Phase 2a Trial

Haney, M.; Vallée, M.; Fabre, S.; Collins Reed, S.; Zanese, M.; Campistron, G.; Arout, C. A.; Foltin, R. W.; Cooper, Z. D.; Kearney-Ramos, T.; Metna, M.; Justinova, Z.; Schindler, C.; Herbert-Chatelain, E.; Bellochio, L.; Cathala, A.; Bari, A.; Serrat, R.; Finlay, D. B.; Caraci, F.; Redon, B.; Martin-Garcia, E.; Busquets-Garcia, A.; Matias, I.; Levin, F. R.; Felpin, F.-X.; Simon, N.; Cota, D.; Spampinato, U.; Maldonado, R.; Shaham, Y.; Glass, M.; Thomsen, L. L.; Mengel, H.; Marsicano, G.; Monlezun, S.; Revest, J.-M.; Piazza, P. V.
Nat. Med. 2023, 29, 1487-1499, DOI

© François-Xavier Felpin 2017-2024
© Loïs De Sauvecanne 2017-2024